Whitefort Capital Management, LP
Follow13F filer, CIK 1884931, NEW YORK, NY
Whitefort Capital Management, LP reported $219,608,194 across 18 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 92.91% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-24-000972
- Period
- 2024-09-30
- Reported value
- $220M
- Holdings
- 18
- Top 10 weight
- 92.91%
- New
- 2
- Sold out
- 7
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| EDRnew | +1,000,000 | $28.6M |
| JOYYadded | +354,932 | $12.9M |
| CORZadded | +885,000 | $10.5M |
| LQDAadded | +927,546 | $9.28M |
| GNWadded | +990,000 | $6.78M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| LIBERTY MEDIA CORP DELexited | -456,285 | -$10.1M |
| ESPRexited | -2,299,121 | -$5.1M |
| OMEXexited | -548,909 | -$2.68M |
| CORZZexited | -250,000 | -$2.17M |
| PBIexited | -373,500 | -$1.9M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0001013594-24-000972, largest first. % of portfolio is the value over $219,608,195, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ABUSARBUTUS BIOPHARMA CORP | 12,867,967 | $49.5M | 22.56% | 0 | Timeline | ||
| EDRENDEAVOR GROUP HLDGS INC | 1,000,000 | $28.6M | 13% | new | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 2,391,000 | $27.6M | 12.56% | 0 | Timeline | ||
| JOYYJOYY INC | 565,878 | $20.5M | 9.34% | +354,932 | Timeline | ||
| GNWGENWORTH FINL INC | 2,986,960 | $20.5M | 9.32% | +990,000 | Timeline | ||
| LQDALIQUIDIA CORPORATION | 1,702,025 | $17M | 7.75% | +927,546 | Timeline | ||
| CORZCORE SCIENTIFIC INC NEW | 1,147,500 | $13.6M | 6.2% | +885,000 | Timeline | ||
| GSLGLOBAL SHIP LEASE INC | 366,771 | $9.77M | 4.45% | 0 | Timeline | ||
| NNNEXTNAV INC | 1,252,831 | $9.38M | 4.27% | -247,823 | Timeline | ||
| MAIDEN HOLDINGS LTDMAIDEN HOLDINGS LTD | 2,048,163 | $3.63M | 1.65% | 0 | |||
| NNAVWNEXTNAV INC | 482,951 | $1.4M | 0.64% | 0 | Timeline | ||
| VATEINNOVATE CORP | 320,131 | $1.18M | 0.54% | new | Timeline | ||
| OPKOPKO HEALTH INC | 134,490 | $200K | 0.09% | -268,700 | Timeline | ||
| TRIBTRINITY BIOTECH INVT LTD | 81,902 | $90.1K | 0.04% | 0 | Timeline | ||
| ALTENERGY ACQUISITION CORPALTENERGY ACQUISITION CORP | 186,315 | $2.09K | <0.01% | 0 |
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| Esperion Therapeutics IncEsperion Therapeutics Inc NOTE 4.000%11/15/25 | principal | 8,000,000 | $7.59M | 0 |
| SABRE GLBL INCSABRE GLBL INC BOND | principal | 5,000,000 | $4.97M | 0 |
| INNOVATE CORPINNOVATE CORP NOTE 7.500% 8/0 | principal | 12,218,000 | $4.1M | +3,560,000 |
Sold out in Q3 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| LIBERTY MEDIA CORP DELLIBERTY MEDIA CORP DEL | 456,285 | $10.1M | shares |
| ESPRESPERION THERAPEUTICS INC NE | 2,299,121 | $5.1M | shares |
| OMEXODYSSEY MARINE EXPL INC | 548,909 | $2.68M | shares |
| CORZZCORE SCIENTIFIC INC NEW | 250,000 | $2.17M | shares |
| PBIPITNEY BOWES INC | 373,500 | $1.9M | shares |
| INNOVATE CORPINNOVATE CORP | 1,288,917 | $779K | shares |
| LANVIN GROUP HOLDINGS LIMITELANVIN GROUP HOLDINGS LIMITE | 100,000 | $3.53K | shares |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001013594-24-000972 | base | 2024-11-14 | acceptance time not in the bulk data set |